About Karah Parschauer
Karah Parschauer is EVP and Chief Legal Officer at Ultragenyx Pharmaceutical.
Form D filings name Karah Parschauer as an executive officer at Amlogenyx.
Karah Parschauer reports to the SEC as a director or officer of 5 public companies, including Tenaya Therapeutics (TNYA), Evolus (EOLS) and Anebulo Pharmaceuticals (ANEB).
Karah Parschauer first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Karah Parschauer in the role, so the role may have started earlier or lasted longer.
UI
Ultragenyx Pharmaceutical Inc.
EVP and Chief Legal Officer
2016 – 2026 · Public company (RARE)
Amlogenyx Inc.
Executive officer
2026 · Novato, CA
Develops an investigational gene therapy for people with Alzheimer's disease.
TI
Tenaya Therapeutics, Inc.
Director
2021 – 2026 · Public company (TNYA)
EI
Evolus, Inc.
Director
2019 – 2026 · Public company (EOLS)
AI
Anebulo Pharmaceuticals, Inc.
Director
2021 – 2022 · Public company (ANEB)
AI
Arcturus Therapeutics Holdings Inc.
Director
2019 – 2021 · Public company (ARCT)
Key Colleagues at Startups
The people Karah Parschauer works with at each company, as listed on that company's latest Form D.
Amlogenyx Inc. · Form D, Jul 9, 2026
John Pinion
Chief Operations Officer
Craig Gordon
Director
Sukumar Nagendran
Director
Emil Kakkis
Founder and Chairman
TH
Ted Huizenga
Executive officer